Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. - Wikidata - awgldk - TriplyDB

Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.

Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.

http://www.wikidata.org/entity/Q33436297

about

Biostatistics: a toolkit for exploration, validation, and interpretation of clinical data.Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.Specific organ metastases and survival in small cell lung cancer Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer.The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.Progress in the management of limited-stage small cell lung cancer.Importance of ABCC1 for cancer therapy and prognosis.Prognostic value of Ki-67 expression in patients with extensive-stage small cell lung cancer.Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma.Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer.The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer.Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions.A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.[First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries

P2860

Q33518386-0785AED2-6C8E-423C-A361-26043985D750 Q33798652-D1446304-F95E-44F1-93D0-0630F96E7FD4 Q34512144-FE336E0A-E05E-487E-9D21-3836E4566F0A Q34991328-069082BF-E481-44E9-A2C3-27A4017ECD74 Q36424117-1453CC0D-4340-42E5-A0B6-F1C6738BC4DA Q36657575-0F82DE73-7555-4DDB-9ABA-B2F69697977B Q36707857-9364249E-6502-40B4-8E76-77C68490789C Q36857674-EEACB6F8-F6F0-4F68-A5F8-54A7945399E9 Q37178855-C3B76214-8A61-40F7-BFC4-E81472BCA483 Q37283557-E1B3C36B-91A2-4B5D-B860-FAAAE21FBA32 Q37626969-75162F95-C84E-4A47-B59F-4D6416B27AA0 Q38199535-31741D1F-87CA-444E-B759-B96267D24670 Q38673828-071B5CBC-145D-471C-B14E-62382D9144E7 Q38996164-D20AE1C0-059D-460B-92BE-5DF45DB4AE8B Q40269165-44FE6F39-D34B-4A4F-9D3B-0376B84D24B6 Q43139088-CFB32F20-FFEB-4CF8-8659-14ECBAFAA4B4 Q45226424-C19EB258-FBD3-4C0D-AD37-B48041A8953B Q48277835-52B66DD0-3420-4AEF-AF79-1D95E01950F7 Q49344235-7CFA08B3-EAFC-4417-A7BE-3151A1671B90 Q51701867-5769DF8B-3274-4867-A017-B39F7557DFDA Q53109417-D420CB77-5210-428D-BAE6-084147C70BAA Q55428299-4F78146B-1F74-4C08-888E-29642ECCE736 Q59127285-B449EEEB-B4CB-4A81-B20C-B596C20BE56E

P2860

Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.

http://www.wikidata.org/entity/Q33436297

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@ast

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@en

type

label

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@ast

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@en

prefLabel

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@ast

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@en

P1433

Q33436297-72A0A3D4-027D-4C04-A5B8-D9719234D054

P1476

Q33436297-1D7FE304-F783-49C7-9437-BE12F099D892

P2093

Q33436297-16E07727-F17C-42B2-B7FA-2157E38FDAC7

Q33436297-211BF320-51CB-4A59-878A-9FBE0005A394

Q33436297-309AF242-765E-4672-A260-0F2681DB0605

Q33436297-34BE7B6B-83DC-4961-8D6A-4F29831C8083

Q33436297-353F77EA-BBA0-4CAD-8EC1-E74456A6A1B1

Q33436297-3D8B2327-CE90-4453-847F-696351660058

Q33436297-4F7F1E94-D752-471D-AB02-7260C4303EB4

Q33436297-6BBD9216-E74B-4AA3-8F9A-3522232B03BD

Q33436297-A0134238-2F92-4ABC-871B-E102E7DBC334

P2860

Q33436297-03949BF7-FB5A-4625-9B47-D0B262A7FE46

Q33436297-07A68DB8-B38A-4A7C-A3A1-094E8CEFE849

Q33436297-082AD3C4-11B1-4FB6-8100-B0F1DAB7E56B

Q33436297-090E202C-0A03-4CC9-B2B6-9F86BA307130

Q33436297-2728321E-E25E-4969-ABD6-CF1DF46B356C

Q33436297-33F5FA47-399F-4801-961F-3F130C477310

Q33436297-35023898-6D28-4A76-A69E-DAA793E4DF5D

Q33436297-3CE8AAAA-C407-46EC-9588-3ABACF3BB993

Q33436297-52DAE3EE-7ABA-46D6-AC6C-F96CD7F1765A

Q33436297-57A87272-B04E-46F0-96BB-DD94D968F97C

P304

Q33436297-980BF211-8F05-48A0-8C38-208E5BE4F0D8

P31

Q33436297-07C5CDC6-B1BD-4E14-8174-0E7B4B190C80

Q33436297-503ec502-0a50-440a-8db9-7f853db69f9c

P356

Q33436297-53480783-6DBB-4D6D-98A1-C70834205F80

P407

Q33436297-958FD5D4-E288-4110-B3D5-31054178755B

P433

Q33436297-5B71D3E3-1D4F-4276-B8A9-AFED89943EB5

P478

Q33436297-E7412A39-F129-4083-80EF-EDCEB69AA9AC

P50

Q33436297-8BC01A77-CAE5-47D7-ACAD-BB644A50B986

P577

Q33436297-010C607E-9FF0-4D30-8922-3447E24D2E16

P5875

Q33436297-F42D6274-0F53-4B22-AC1F-A9417E4C5E30

P698

Q33436297-EB6ED412-B134-433B-9D63-DE04430E3C45

P932

Q33436297-6962DC64-127C-4908-913F-29BD7F664CD5

P356

P1433

P1476

Prognostic factors differ by t ...... Cancer Treatment Group trials.

@en

P2093

Alex A Adjei

http://www.w3.org/2001/XMLSchema#string

Garth D Nelson

http://www.w3.org/2001/XMLSchema#string

James R Jett

http://www.w3.org/2001/XMLSchema#string

Kendrith M Rowland

http://www.w3.org/2001/XMLSchema#string

Nathan R Foster

http://www.w3.org/2001/XMLSchema#string

Randolph S Marks

http://www.w3.org/2001/XMLSchema#string

Richard L Deming

http://www.w3.org/2001/XMLSchema#string

Sumithra J Mandrekar

http://www.w3.org/2001/XMLSchema#string

Timothy F Kozelsky

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.

Phase II NCCTG trial of oral topotecan and paclitaxel with G-CSF (filgrastim) support in patients with previously untreated extensive-stage small cell lung cancer.

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.

Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

Prophylactic cranial irradiation in extensive small-cell lung cancer.

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research.

P304

2721-2731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24314

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Steven E Schild

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24377040

http://www.w3.org/2001/XMLSchema#string

P698

19402175

http://www.w3.org/2001/XMLSchema#string

P932

2779694

http://www.w3.org/2001/XMLSchema#string